Purchases and Sales Made in Q1 2024 in Nurix Therapeutics, Inc. (NRIX)
This table provides information about the institutional ownership of Nurix Therapeutics, Inc. (NRIX) during Q1 2024. The information is specifically focused on institutions that hold shares of Nurix Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-21.2K- 30.88% |
$165K - $332K
|
47.5K
$930K
|
|
|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-22K- 30.34% |
$171K - $345K
|
50.5K
$989K
|
|
|
May 15, 2024
Q1 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-22.3K- 94.5% |
$173K - $349K
|
1.3K
$25.4K
|
|
|
May 15, 2024
Q1 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-22.5K- 58.43% |
$175K - $352K
|
16K
$313K
|
|
|
Apr 05, 2024
Q1 2024
|
Los Angeles Capital Management LLC
|
SELL
|
- |
-23.7K- 18.79% |
$184K - $371K
|
102K
$2M
|
|
|
May 03, 2024
Q1 2024
|
Candriam S.C.A.
|
SELL
|
- |
-26K- 2.83% |
$202K - $407K
|
892K
$17.5M
|
|
|
May 14, 2024
Q1 2024
|
Massachusetts Financial Services CO
Boston, MA |
SELL
|
- |
-29.4K- 20.66% |
$228K - $460K
|
113K
$2.21M
|
|
|
May 10, 2024
Q1 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-33.6K- 3.36% |
$261K - $526K
|
966K
$18.9M
|
|
|
May 15, 2024
Q1 2024
|
Hsbc Holdings PLC
London, X0 |
SELL
|
- |
-33.6K- 49.98% |
$261K - $527K
|
33.7K
$659K
|
|
|
May 14, 2024
Q1 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-46.6K- 6.03% |
$362K - $730K
|
727K
$14.2M
|
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-63.3K- 1.36% |
$492K - $992K
|
4.58M
$89.6M
|
|
|
May 15, 2024
Q1 2024
|
Kennedy Capital Management, Inc.
St Louis, MO |
SELL
|
- |
-72.8K- 45.18% |
$565K - $1.14M
|
88.3K
$1.73M
|
|
|
May 13, 2024
Q1 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-115K- 21.55% |
$894K - $1.8M
|
419K
$8.2M
|
|
|
May 15, 2024
Q1 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-194K- 8.11% |
$1.51M - $3.03M
|
2.2M
$43M
|
|
|
Apr 18, 2024
Q1 2024
|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
SELL
|
- |
-560K- 17.52% |
$4.35M - $8.76M
|
2.64M
$51.6M
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-604K- 19.27% |
$4.69M - $9.46M
|
2.53M
$49.5M
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-604K- 19.27% |
$4.69M - $9.46M
|
2.53M
$49.5M
|
|
|
May 15, 2024
Q1 2024
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
SELL
|
- |
-690K- 37.88% |
$5.37M - $10.8M
|
1.13M
$22.2M
|
|
|
Apr 18, 2024
Q1 2024
|
Wasatch Advisors Inc
Salt Lake City, UT |
SELL
|
- |
-1.51M- 55.02% |
$11.8M - $23.7M
|
1.24M
$24.2M
|